Patent details
301074
Product Name:
onasemnogene abeparvovec, in enige vorm zoals beschermd door het basisoctrooi
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301074
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2185712
Status:
Withdrawn
Application number:
301074
Procedural language:
Dutch
First Applicant Residence Country:
France (FR)
Marketing Authorization
Marketing Authorization Number:
EU/1/20/1443
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/05/2020
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
18/11/2020
First Marketing Authorization date:
18/05/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
18/11/2020
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
12/01/2023
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
18/11/2020
Name:
GENETHON
Address:
1 bis rue de l'Internationale
Boîte Postale 60, 91002 Evry Cedex, France (FR)
From:
18/11/2020
Name:
Centre National de la Recherche Scientifique
Address:
3, rue Michel-Ange, 75016 PARIS, France (FR)
Agent
Name:
ir. H.A. Witmans c.s.
From:
18/11/2020
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
03/23
Publication date:
18/01/2023
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
48/20
Publication date:
25/11/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
16/01/2023
Outgoing Correspondence
Letter confirmation withdrawal
1
PDF
/9/6/0/5/2/0800625069/docs/301074_11_526119l193.pdf
12/01/2023
SPC Documents
Withdrawal SPC
1
PDF
/9/6/0/5/2/0800625069/docs/301074_12_supplprotectioncertificate20230112042341896.pdf
18/11/2020
SPC Documents
Annex SPC
3
PDF
/9/6/0/5/2/0800625069/docs/301074_0_supplprotectioncertificate20201118123055307.pdf
18/11/2020
SPC Documents
Annex SPC
7
PDF
/9/6/0/5/2/0800625069/docs/301074_1_supplprotectioncertificate20201118123055511.pdf
18/11/2020
SPC Documents
Marketing Authorization SPC
3
PDF
/9/6/0/5/2/0800625069/docs/301074_2_supplprotectioncertificate20201118123055200.pdf
18/11/2020
SPC Documents
Annex SPC
2
PDF
/9/6/0/5/2/0800625069/docs/301074_3_supplprotectioncertificate20201118123055457.pdf
18/11/2020
SPC Documents
Annex SPC
18
PDF
/9/6/0/5/2/0800625069/docs/301074_4_supplprotectioncertificate20201118123055374.pdf
18/11/2020
Front Page
Front Page
1
PDF
/9/6/0/5/2/0800625069/docs/301074_5_i1frontpage20201118142218638.pdf
18/11/2020
Outgoing Correspondence
Confirmation receipt request
1
PDF
/9/6/0/5/2/0800625069/docs/301074_6_379100l174.pdf
18/11/2020
Application Form
First filed application form
3
PDF
/9/6/0/5/2/0800625069/docs/301074_7_applicationform20201118123055042.pdf
18/11/2020
SPC Documents
Summary of the characteristics of the product
19
PDF
/9/6/0/5/2/0800625069/docs/301074_8_supplprotectioncertificate20201118123055251.pdf
18/11/2020
SPC Documents
Accompanying letter SPC
2
PDF
/9/6/0/5/2/0800625069/docs/301074_9_supplprotectioncertificate20201118123055149.pdf
18/11/2020
Publication
Publication
1
PDF
/9/6/0/5/2/0800625069/docs/301074_10_i1document20201118142219203.pdf